作者：
Elizabeth,England [1]
;
D Gareth,Rees [1]
;
Ian Christopher,Scott [2]
;
Sara,Carmen [1]
;
Denice T Y,Chan [1]
;
Catherine E,Chaillan Huntington [1]
;
Kirsty F,Houslay [3]
;
Teodor,Erngren [4]
;
Mark,Penney [5]
;
Jayesh B,Majithiya [3]
;
Laura,Rapley [3]
;
Dorothy A,Sims [6]
;
Claire,Hollins [3]
;
Elizabeth C,Hinchy [3]
;
Martin D,Strain [1]
;
Benjamin P,Kemp [1]
;
Dominic J,Corkill [7]
;
Richard D,May [3]
;
Katherine A,Vousden [1]
;
Robin J,Butler [1]
;
Tomas,Mustelin [8]
;
Tristan J,Vaughan [1]
;
David C,Lowe [1]
;
Caroline,Colley [1]
;
E Suzanne,Cohen [9]
作者单位：
Biologics Engineering, R&D, AstraZeneca, Cambridge, UK.
[1]
Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
[2]
Bioscience Asthma and Skin Immunity, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
[3]
Drug Metabolism and Pharmacokinetics, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
[4]
Early Oncology DMPK, Oncology R&D, AstraZeneca, Cambridge, UK.
[5]
Bioscience Asthma and Skin Immunity, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
[6]
Bioscience In Vivo, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
[7]
Division of Rheumatology, Department of Medicine, University of Washington, Seattle, WA, USA.
[8]
Bioscience Asthma and Skin Immunity, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK. suzanne.cohen@astrazeneca.com.
[9]
DOI
10.1038/s41598-023-36642-y
PMID
37330528
发布时间
2023-11-22
换一批
换一批
